Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|April 10, 2015
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo CharacterizationDeborah S Mortensen, Kimberly E Fultz, Shuichan Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.Journal of Medicinal Chemistry|June 24, 2015
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.Journal of Medicinal Chemistry|June 18, 2015
Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.Pageof 2